Heather Munroe-Blum, Principal and Vice-Chancellor of McGill University, and Dr. Arthur T. Porter, Director General and Chief Executive Officer of the McGill University Health Centre (MUHC), welcomed today the announcement by the Canada Foundation for Innovation (CFI) that the Research Institute of the MUHC and McGill University have been awarded $99,988,343 in funding.
This award represents the largest infrastructure investment the CFI has ever made, and will be used to create and equip a new, state-of-the-art medical research centre as part of the MUHC’s new facilities on the Glen Campus.
“McGill has been at the forefront of medical discovery for almost 200 years,” Prof. Munroe-Blum said. “This important award supports our commitment to remain at the forefront of medical discovery for future generations of physicians and scientists. Our scientists at McGill and the MUHC share this commitment and have been rewarded for their efforts and vision. I am proud and delighted. The kinds of transformative scientific discoveries and advancements that will be made in this state-of-the-art facility will have worldwide repercussions in health care for generations to come.”
“Thanks to the CFI, our plan to bring together our investigators on the Glen and Mountain campuses in order to bridge biomedical research and clinical medicine is assured,” noted Dr. Arthur T. Porter. “The award will support building areas of roughly 40,000 GSM (400,000 GSF) for the Research Institute’s Centre for Innovative Medicine, Centre for Translational Biology and Evaluative Research infrastructure on the Glen Campus. The addition of research neighbourhoods, shared platforms and equipment for 180 clinical, evaluative and biomedical researchers will enhance the MUHC’s capacity for meaningful innovation dramatically. I am tremendously proud of the leadership of our Research Institute’s Director, Dr. Vassilios Papadopoulos, and the entire MUHC-McGill team who worked on this landmark application.”
The new Research Institute of the MUHC at the Glen Campus will house some of the most advanced scientific facilities, equipment and technology. It will bring together researchers in both pediatric and adult medicine, promoting discoveries that will yield new treatments and cures for patients of all ages. The CFI grant will be matched by an additional $100 million in funding from the Quebec government and approximately $50 million in funds from donors.
“Our researchers are currently spread out over more than 65 separate labs located in 50- to 100-year-old buildings that impose severe constraints on their activities,” said Dr. Vassilios Papadopoulos, Director of the Research Institute of the MUHC. “Given the world-class achievements of our scientists and clinicians in these poor conditions, one can only dream of the discoveries that will emerge from a modern facility that is designed to encourage the interdisciplinary collaborations and synergies that are the basis for true scientific innovation.”
Denis Thérien, Vice-Principal, Research and International Relations at McGill, echoed Dr. Papadopoulos' enthusiasm. “This historic decision by the CFI underscores the absolute need of partnerships, harnessing the strengths and resources of governments, the private sector, and world-class institutions like McGill and the MUHC,” Thérien said. “Together, truly transformative research requiring this level of investment and collaboration is possible, and we applaud the CFI’s vision in supporting our exciting project.”
“This award represents a strategic boost to the research capacity of McGill University and the MUHC,” said Dr. Eliot Phillipson, President and CEO of the CFI. “This project, selected through a rigorous assessment process, will help ensure that researchers and graduate students at the MUHC have access to a world-class research facility and training environment.”
About the CFI
The CFI is an independent corporation created in 1997 by the Government of Canada to fund research infrastructure. The CFI's mandate is to strengthen the capacity of Canadian universities, colleges, research hospitals, and non-profit research institutions to carry out world-class research and technology development that benefits Canadians. Since its creation, the CFI has committed more than $3.8 billion in support of 5,746 projects at 128 research institutions in 64 municipalities across Canada.About McGill University
About the Research Institute of the McGill University Health Centre (RI MUHC)
The RI MUHC is a world-renowned biomedical and health-care hospital research centre. Located in Montreal, Quebec, the institute is the research arm of the MUHC, the university health centre affiliated with the Faculty of Medicine at McGill University. The institute supports more than 600 researchers, nearly 1,200 graduate and post-doctoral students and operates more than 300 laboratories devoted to a broad spectrum of fundamental and clinical research. The Research Institute operates at the forefront of knowledge, innovation and technology and is inextricably linked to the clinical programs of the MUHC, ensuring that patients benefit directly from the latest research-based knowledge. The Research Institute of the MUHC is supported in part by the Fonds de la recherche en santé du Québec.Contact:
Julie Fortier | McGill University
How Humans and Machines Navigate Complex Situations
19.11.2018 | Max-Planck-Institut für Bildungsforschung
A gene activated in infant and young brains determines learning capacity in adulthood
13.11.2018 | Universitätsklinikum Hamburg-Eppendorf
Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices
The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...
Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.
Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.
After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.
"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.
Superconductivity approaching room temperature may be possible in hydrogen-rich compounds at much lower pressures than previously expected
Reaching room-temperature superconductivity is one of the biggest dreams in physics. Its discovery would bring a technological revolution by providing...
At the end of December 2019, the first cases of pneumonia caused by a novel coronavirus were reported from the Chinese city of Wuhan. Since then, infections...
12.02.2020 | Event News
16.01.2020 | Event News
15.01.2020 | Event News
14.02.2020 | Physics and Astronomy
14.02.2020 | Physics and Astronomy
14.02.2020 | Physics and Astronomy